Omeros Corporation (NASDAQ:OMER) announced that the U.S. Food and Drug Administration (FDA) has approved Omidria (phenylephrine and ketorolac injection) 1%/0.3% for use during cataract surgery or intraocular lens replacement (ILR) to maintain pupil size by preventing intraoperative miosis (pupil constriction) and to reduce postoperative pain. The approval comes with no post-marketing commitments other than the previously agreed study of Omidria for use in pediatric patients, which, if successfully completed, makes the drug eligible for an additional six months of marketing exclusivity in the U.S. Omeros Corporation (NASDAQ:OMER) stock opened today at $12.33 and is currently trading at $12.23. The stock showed a positive weekly performance of 12.19%.
Apple Inc. (NASDAQ:AAPL) is expected to share the details of its latest software updates for its mobile and desktop devices today as the gadget maker kicks off its annual developer’s conference this morning in San Francisco. Apple Inc. (NASDAQ:AAPL) stock opened at $633.96, in current trading session and currently is at $627.36, by losing -0.89%. The 52 week range of $388.87 – $644.17. Company’s market capitalization is 540.40 billion.
Facebook Inc. (NASDAQ:FB) had reportedly been courting Titan but the social media company chose instead to acquire U.K.-based drone maker Ascenta. Facebook Inc. (NASDAQ:FB) stock is currently trading at $62.71. The EPS of the stock is 0.79. Company’s market capitalization is 160.94 billion.
Keep a close eye on NPS Pharmaceuticals, Inc. (NASDAQ:NPSP). Rumours surfaced that the company could be the target of a buyout. According to a report from The Times of London, Shire plc has lined up a $5 billion credit facility from banks to finance a takeover offer for NPSP. NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) stock opened the session at $37.18, and now is at $35.50. The 52 week range of the NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) stock remained $14.06 – $39.68 and the day range was $35.44 – $37.85.
Semiconductor solutions provider Broadcom Corporation (NASDAQ:BRCM) has its sight set on big things in the coming years. As such, the company is not interested in businesses that will distract its progress. One such business that needs immediate consideration is Broadcom’s cellular baseband business. The company is flexible to pursue any opportunity with the baseband unit, and that included the sale or wind-down. Broadcom Corporation (NASDAQ:BRCM) stock opened today at $36.00 and is currently trading at $34.50. The stock showed a positive weekly performance of 6.13%.
Leave a Reply